Market revenue in 2019 | USD 147.1 million |
Market revenue in 2027 | USD 304.9 million |
Growth rate | 9.5% (CAGR from 2019 to 2027) |
Largest segment | Functional food & beverages |
Fastest growing segment | Dietary Supplements |
Historical data covered | 2016 - 2018 |
Base year for estimation | 2019 |
Forecast period covered | 2020 - 2027 |
Quantitative units | Revenue in USD million |
Market segmentation | Functional Food & Beverages, Dietary Supplements, Other Products |
Key market players worldwide | Danone SA, Yakult Honsha Co Ltd, United Natural Foods Inc, Pfizer Inc, Sabinsa Corporation, Probiotical, Synbiotic Health, NUtech Ventures |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to synbiotic product market will help companies and investors design strategic landscapes.
Functional food & beverages was the largest segment with a revenue share of 87.08% in 2019. Horizon Databook has segmented the Asia Pacific synbiotic product market based on functional food & beverages, dietary supplements, other products covering the revenue growth of each sub-segment from 2016 to 2027.
Asia Pacific is estimated to be the fastest-growing market for synbiotic products due to the rapidly growing economies of China, India, and South Korea. Synbiotic products have witnessed a significant increase in demand in the region due to the high prevalence of conditions such as diarrhea, irritable bowel syndrome (IBS), lactose intolerance, cardiovascular diseases, cancer, obesity, and increasing incidences of nosocomial infections in surgical patients.
A majority of the consumers in the region are opting for synbiotic supplements and products to increase the mineral content in their body as well as ensure effective functioning of the body. Such benefits are likely to boost the product demand among consumers.
In Asia Pacific, synbiotics are increasingly adopted by the elderly since many of them suffer from chronic health conditions such as undernutrition and metabolic imbalance. This has led to an increasing interest in non-invasive treatments such as the consumption of synbiotics, probiotics, and prebiotics.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific synbiotic product market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific synbiotic product market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account